Lab Updates

Collagen-Binding Assay Work-up for Von Willebrand Disease

Lab Updates
Collagen-Binding Assay Work-up for Von Willebrand Disease
Read Document

September 2024
Ampath | ampath.co.za

Overview

Von Willebrand Disease (VWD) is the most common inherited bleeding disorder, affecting approximately 1 in 1,000 people. It is caused by:

  • Defects in or reduced levels of Von Willebrand Factor (VWF)

Role of VWF in Haemostasis:

  • Carrier protein for Factor VIII
  • Facilitates platelet adhesion to vessel walls
  • Promotes platelet aggregation

Classification of VWD

Type 1 – Mild Quantitative Defect

  • Reduced amount of VWF

Type 2 – Qualitative/Functional Defect

  • Normal quantity but defective activity
  • Subtypes:
    • Type 2A: Impaired multimerisation (loss of high molecular weight multimers – HMWM)
    • Type 2B: Hyper-functional platelet binding (also with HMWM loss)
    • Type 2M: Decreased GP1b binding
    • Type 2N: Decreased Factor VIII binding

Type 3 – Severe Total Quantitative Defect

  • No VWF production

Laboratory Diagnosis of VWD

🧪 Initial Screening Panel (Three Tests):

  1. VWF: Antigen (VWF: Ag)
  2. VWF: Ristocetin cofactor activity (VWF: RCo)
  3. Factor VIII level

🔎 Interpretation by VWF: RCo / VWF: Ag Ratio:

  • Type 1 VWD:
    • Proportional reduction in both VWF antigen and activity
    • Ratio: > 0.7
  • Type 2 VWD:
    • Discrepant levels: VWF activity is reduced more than antigen
    • Ratio: < 0.7

Role of the Collagen-Binding Assay (VWF: CB)

  • Performed when VWF: RCo / VWF: Ag ratio < 0.7 (suggests type 2 VWD)
  • Detects binding of high molecular weight multimers (HMWM) to collagen
  • Helps differentiate type 2 subtypes:
    • VWF: CB / VWF: Ag ratio < 0.7 suggests Type 2A or 2B VWD

Ampath’s 4-Test VWD Panel Includes:

  1. VWF: Ag
  2. VWF: RCo
  3. Factor VIII
  4. Collagen-Binding Assay (VWF: CB) (performed only if needed based on initial results)

Test Information – VWF: CB (Collagen-Binding Assay)

  • Mnemonic: VWCB
  • Specimen type: Venous blood
  • Container: Citrate tube (3.2% trisodium citrate solution)
  • Volume required:
    • 9 parts venous blood to 1 part citrate
  • Transport instructions:
    • Must reach the lab within 4 hours
    • If delayed: centrifuge, freeze, and send frozen
  • Turnaround time: 72 hours
  • Indications for testing:
    • Family history of bleeding
    • Mucosal bleeding
    • Easy bruising
    • Epistaxis (nosebleeds)
    • Gingival bleeding
    • Excessive surgical bleeding
    • Heavy menstrual bleeding

📌 For additional support, contact your Ampath haematology consultant or local representative.